Ameren (AEE) Price Target Cut to $65.00 by Analysts at Morgan Stanley

Share on StockTwits

Ameren (NYSE:AEE) had its price objective cut by analysts at Morgan Stanley from $67.00 to $65.00 in a research note issued on Friday, September 21st. The firm presently has an “equal weight” rating on the utilities provider’s stock. Morgan Stanley’s target price suggests a potential upside of 1.88% from the company’s previous close.

Other equities research analysts also recently issued reports about the stock. Zacks Investment Research upgraded shares of Ameren from a “hold” rating to a “buy” rating and set a $66.00 target price for the company in a research note on Tuesday, May 29th. Barclays initiated coverage on shares of Ameren in a report on Tuesday, July 10th. They issued an “equal weight” rating and a $63.00 price target on the stock. Goldman Sachs Group reissued a “neutral” rating on shares of Ameren in a report on Friday, June 1st. Finally, Wells Fargo & Co increased their price target on shares of Ameren from $67.00 to $71.00 and gave the company an “outperform” rating in a report on Monday, September 17th. Six analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Ameren presently has a consensus rating of “Hold” and a consensus price target of $64.56.

AEE stock traded down $0.24 during trading hours on Friday, reaching $63.80. 2,405,259 shares of the stock were exchanged, compared to its average volume of 1,619,794. Ameren has a 12 month low of $51.89 and a 12 month high of $67.06. The company has a current ratio of 0.62, a quick ratio of 0.45 and a debt-to-equity ratio of 1.01. The stock has a market cap of $15.43 billion, a PE ratio of 22.54, a price-to-earnings-growth ratio of 3.01 and a beta of 0.20.

Ameren (NYSE:AEE) last posted its quarterly earnings data on Friday, August 3rd. The utilities provider reported $0.97 EPS for the quarter, topping the Zacks’ consensus estimate of $0.79 by $0.18. Ameren had a net margin of 9.85% and a return on equity of 10.60%. The company had revenue of $1.56 billion during the quarter, compared to the consensus estimate of $1.54 billion. During the same period in the prior year, the business posted $0.79 EPS. The company’s quarterly revenue was up 1.7% on a year-over-year basis. On average, analysts forecast that Ameren will post 3.25 earnings per share for the current fiscal year.

A number of large investors have recently made changes to their positions in the stock. Adviser Investments LLC acquired a new stake in Ameren in the first quarter valued at approximately $105,000. Rampart Investment Management Company LLC acquired a new stake in Ameren in the second quarter valued at approximately $150,000. Orrstown Financial Services Inc. acquired a new stake in Ameren in the second quarter valued at approximately $152,000. Bronfman E.L. Rothschild L.P. boosted its position in Ameren by 274.3% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 2,553 shares of the utilities provider’s stock valued at $155,000 after buying an additional 1,871 shares in the last quarter. Finally, Centaurus Financial Inc. acquired a new position in shares of Ameren during the second quarter worth $166,000. 70.46% of the stock is currently owned by institutional investors and hedge funds.

About Ameren

Ameren Corporation operates as a public utility holding company in the United States. It operates through four segments: Ameren Missouri, Ameren Illinois Electric Distribution, Ameren Illinois Natural Gas, and Ameren Transmission. The company engages in the rate-regulated electric generation, transmission, and distribution activities; and rate-regulated natural gas distribution and transmission businesses.

Featured Article: What is insider trading?

Analyst Recommendations for Ameren (NYSE:AEE)

Receive News & Ratings for Ameren Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ameren and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.